Invention Grant
- Patent Title: PPARG modulators for treatment of osteoporosis
-
Application No.: US15302862Application Date: 2015-04-16
-
Publication No.: US10016394B2Publication Date: 2018-07-10
- Inventor: Patrick R. Griffin , Theodore Mark Kamenecka , Beata Lecka-Czernik
- Applicant: The Scripps Research Institute , University of Toledo
- Applicant Address: US CA La Jolla
- Assignee: The Scripps Research Institute
- Current Assignee: The Scripps Research Institute
- Current Assignee Address: US CA La Jolla
- Agent Geoffrey K. Cooper; Thomas Fitting
- International Application: PCT/US2015/026226 WO 20150416
- International Announcement: WO2015/161108 WO 20151022
- Main IPC: A61K31/404
- IPC: A61K31/404 ; A61K31/41 ; C07D209/18 ; A61K31/5377 ; A61K31/4709 ; A61K31/454 ; A61K31/4245 ; A61K31/4439 ; A61K31/4045 ; C07D209/08
Abstract:
The invention provides methods of treatment of a progressive bone disease, such as osteoporosis, Paget's Disease, multiple myeloma, or hyperparathyroidism, comprising administration of an effective amount of a non-agonist PPARG modulator to a patient afflicted with the disease.
Public/Granted literature
- US20170035730A1 PPARG MODULATORS FOR TREATMENT OF OSTEOPOROSIS Public/Granted day:2017-02-09
Information query
IPC分类:
